China's Biotech Rise: Impacts on Global Drug Development

This chapter examines the growing influence of China's biotech sector in drug development, as highlighted in discussions from the recent JPM conference. It covers the competitive dynamics between Chinese and U.S. biotechs, including insights on the emergence of obesity-related startups and the increasing collaboration between Chinese firms and U.S. investors. The conversation also addresses the challenges faced by U.S. startups in keeping pace with China's rapid advancements and the potential catalysts for innovation in response to this competition.